Developer docs
API playgroundTry for free, no card

Search company profiles

Elbit Imaging Ltd.

Full company profile

uuid003fa9c

Namestring
Elbit Imaging Ltd.
Websiteurl
elbitimaging.com
Company typeenum
Private
Founded yearint
1996
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersTel Aviv, Israel
HQ citystring
Tel Aviv
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Product category
Unknown
No data
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

No information about Elbit Imaging Ltd.'s core offerings is available in the source material; the company website displays only a default Plesk web hosting placeholder page.

Differentiator
Functional benefit
Problem solved
No data
Market position
Customer concentration

Classification, Details

No data
Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment6 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Elbit Imaging Ltd.

Unknownelbitimaging.com

Elbit Imaging Ltd. firmographics

Firmographics
Name
Elbit Imaging Ltd.
Website
https://elbitimaging.com
Company type
Private
Founded year
1996
Headcount range
1,001–5,000 employees
Ownership category
akta.pro rank

Where Elbit Imaging Ltd. is headquartered

Location

Headquarters

HQ city
Tel Aviv
HQ country
Israel
HQ region
Middle East

Markets served

Elbit Imaging Ltd. business model

Business model
GTM type
B2B
Offering type
Services

Elbit Imaging Ltd. product offering

Product offering

Core offering

No information about Elbit Imaging Ltd.'s core offerings is available in the source material; the company website displays only a default Plesk web hosting placeholder page.

Differentiator

Problem solved

Functional benefit

Elbit Imaging Ltd. technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Elbit Imaging Ltd. competitors and assessment

Company assessment

Market position

Customer concentration

Elbit Imaging Ltd. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Elbit Imaging Ltd. leadership team

Management profile

Number of profiles

Elbit Imaging Ltd. funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Elbit Imaging Ltd. M&A and investment

M&A and investment

M&A

Investments6 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Elbit Imaging Ltd.

What does Elbit Imaging Ltd. do?

No information about Elbit Imaging Ltd.'s core offerings is available in the source material; the company website displays only a default Plesk web hosting placeholder page.

When was Elbit Imaging Ltd. founded?

Elbit Imaging Ltd. was founded in 1996. It employs 1,001 to 5,000 people.

Where is Elbit Imaging Ltd. based?

Elbit Imaging Ltd. is headquartered in Tel Aviv, Israel, in the Middle East region.

Does Elbit Imaging Ltd. have an API?

No public API is recorded for Elbit Imaging Ltd..

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireELBIT IMAGING LTD. ANNOUNCES THAT INSIGHTEC RECEIVES FDA APPROVAL AND CE MARK FOR EXABLATE NEURO WITH GE SIGNA PREMIER MRI SYSTEMInsightec received FDA approval and CE mark for Exablate Neuro compatible with GE Healthcare's SIGNA Premier MRI system. The device has FDA approval for medication-refractory essential tremor and tremor-dominant Parkinson's disease, and CE mark for essential tremor, Parkinson's disease, and neuropathic pain. Elbit Imaging holds a stake in Insightec through its subsidiary Elbit Medical Technologies.GlobeNewswireELBIT IMAGING LTD. ANNOUNCES INSIGHTEC MR-GUIDED FOCUSED ULTRASOUND RECEIVES REIMBURSEMENT FROM JAPANESE MINISTRY OF HEALTH, LABOR AND WELFARE FOR THE TREATMENT OF ESSENTIAL TREMORInsightec received national reimbursement from Japan's Ministry of Health, Labour and Welfare for treating essential tremor. The Exablate Neuro device received approval in December 2016, and nine systems are now performing routine MR-guided focused ultrasound treatment in Japan.GlobeNewswireDelisting of Securities of Elbit Imaging Ltd., Helios andNasdaq announced delistings for Elbit Imaging, Helios and Matheson Analytics, Synergy Pharmaceuticals, Kona Grill, Presbia, Fusion Connect, and Achaogen, all of which had been suspended and not traded since February to April 2019. The delistings will take effect ten days after Nasdaq files Form 25 with the SEC.GlobeNewswireELBIT IMAGING ANNOUNCES COMPLETION OF THE FIRST STAGE FOR THE SALE OF UP TO 25% OF THE SHARE CAPITAL OF ELBIT MEDICAL LTD.Elbit Imaging completed the first stage of a share purchase agreement with an SPC related to Exigent Capital Group, selling 3,760,417 shares of Elbit Medical for approximately NIS 3.6 million. The sale represents 1.6% of Elbit Medical's outstanding share capital.GlobeNewswireELBIT IMAGING ANNOUNCES UPDATE REGARDING THE AGREEMENT FOR THE SALE OF UP TO 25% OF THE SHARE CAPITAL OF ELBIT MEDICAL LTD.Elbit Imaging announced it postponed the initial closing of its share purchase agreement with an SPV for Elbit Medical to March 27, 2019, from March 18, 2019. The deal involves selling 25% of Elbit Medical's outstanding shares. The company issued a forward-looking statement warning of risks.GlobeNewswireELBIT IMAGING LTD. ANNOUNCES ADDITIONAL BUYBACK OF NOTES SERIES IElbit Imaging Ltd. completed repurchases of an additional 1,685,616 par value Notes under its buy-back plan. The company has now purchased NIS 111.66 million in Notes for a total cash consideration of NIS 144.26 million.GlobeNewswireELBIT IMAGING LTD. ANNOUNCES ADDITIONAL BUYBACK OF NOTES SERIES IElbit Imaging Ltd. completed repurchases of an additional 4,229,758 par value Notes under its buy-back plan. The company has now purchased par value NIS 113.98 million of Notes for a total cash consideration of NIS 142.05 million.GlobeNewswireELBIT IMAGING ANNOUNCES THE SIGNING OF AN AGREEMENT FOR THE SALE OF UP TO 25% OF THE SHARE CAPITAL OF ELBIT MEDICAL LTD.Elbit Imaging signed a share purchase agreement with an SPV to sell between 1.6% and 25% of Elbit Medical's shares at NIS 0.96-$1.02 per share. The initial closing is due March 18, 2019, with additional purchases possible until May 13, 2019. The SPV has a right of first refusal if a third-party offer exceeds the per-share price by 7.5%.GlobeNewswireELBIT IMAGING LTD. ANNOUNCES FIRST GLIOBLASTOMA PATIENT COMPLETED CHEMOTHERAPY CYCLES WITH BLOOD BRAIN BARRIER DISRUPTION USING INSIGHTEC'S EXABLATE NEUROElbit Imaging and Insightec announced the first patient worldwide completed six chemotherapy cycles with focused ultrasound to disrupt the blood-brain barrier in a glioblastoma trial. No complications occurred, and the device is used after surgery and radiotherapy. The company holds a 63% stake in Elbit Medical Technologies, which holds a 22% stake in Insightec.GlobeNewswireELBIT IMAGING LTD. ANNOUNCES ADDITIONAL BUYBACK OF NOTES SERIES IElbit Imaging Ltd. completed repurchases of an additional 1,100,000 par value Notes under its buy-back plan. The company has now purchased NIS 109.75 million in Notes for NIS 136.53 million, with the plan covering up to NIS 200 million.